• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Six Sigma in the Pharmaceutical Industry: Understanding, Reducing, and Controlling Variation in Pharmaceuticals and Biologics

    Six Sigma in the Pharmaceutical Industry by Nunnally, Brian K.; McConnell, John S.;

    Understanding, Reducing, and Controlling Variation in Pharmaceuticals and Biologics

      • GET 20% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice GBP 190.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        90 772 Ft (86 450 Ft + 5% VAT)
      • Discount 20% (cc. 18 154 Ft off)
      • Discounted price 72 618 Ft (69 160 Ft + 5% VAT)

    90 772 Ft

    db

    Availability

    Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
    Not in stock at Prospero.

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Short description:

    Focuses on the building blocks of understanding and reducing variation using the Six Sigma method as applied specifically to the pharmaceutical industry. This title introduces the fundamentals of Six Sigma, examines control chart theory and practice, and explains the concept of variation management and reduction.

    More

    Long description:

    The pharmaceutical industry is under increasing pressure to do more with less. Drug discovery, development, and clinical trial costs remain high and are subject to rampant inflation. Ever greater regulatory compliance forces manufacturing costs to rise despite social demands for more affordable health care. Traditional methodologies are failing and the industry needs to find new and innovative approaches for everything it does.

    Six Sigma in the Pharmaceutical Industry: Understanding, Reducing, and Controlling Variation in Pharmaceuticals and Biologics is the first book to focus on the building blocks of understanding and reducing variation using the Six Sigma method as applied specifically to the pharmaceutical industry. It introduces the fundamentals of Six Sigma, examines control chart theory and practice, and explains the concept of variation management and reduction. Describing the approaches and techniques responsible for their own significant success, the authors provide more than just a set of tools, but the basis of a complete operating philosophy. Allowing other references to cover the structural elements of Six Sigma, this book focuses on core concepts and their implementation to improve the existing products and processes in the pharmaceutical industry. The first half of the book uses simple models and descriptions of practical experiments to lay out a conceptual framework for understanding variation, while the second half introduces control chart theory and practice. Using case studies and statistics, the book illustrates the concepts and explains their application to actual workplace improvements.

    Designed primarily for the pharmaceutical industry, Six Sigma in the Pharmaceutical Industry: Understanding, Reducing, and Controlling Variation in Pharmaceuticals and Biologics provides the fundamentals of variation management and reduction in sufficient detail to assist in transforming establishe

    More

    Table of Contents:

    The Enormous Initial Mistake, ?The Origins of Six Sigma, Evolution, ?Revolution, ?Paradox, Action and Reaction, Close Enough; ? Or On Target?, ?Make More?Faster, Case Studies, ?The Camera Always Lies, Keeping It Simple, Why Use Control Charts?, ?Average and Range Control Charts, ?Origins and Theory, ?Charts for Individuals, ?Practical Considerations, Improving Laboratories, Beyond Compliance, Appendices

    More
    Recently viewed
    previous
    Six Sigma in the Pharmaceutical Industry: Understanding, Reducing, and Controlling Variation in Pharmaceuticals and Biologics

    Mr. Ambassador ? Warrior for Peace: Warrior for Peace

    Perkins, Edward J.; Cronley, Connie; Shultz, George P.;

    13 849 HUF

    12 465 HUF

    next